Pharmabiz

Pulsenmore receives US FDA De Novo marketing authorization for Pulsenmore ES, a home-use prenatal ultrasound platform

Ramat Gan, Israel Wednesday, November 5, 2025, 12:00 Hrs [IST] ...
Pharmabiz

TScan Therapeutics reaches agreement with US FDA on pivotal study design for TSC-101 and announces strategic prioritization to advance TSC-101

TScan Therapeutics reaches agreement with US FDA on pivotal study design for TSC-101 and announces strategic prioritization to advance TSC-101: Waltham, Massachusetts Wednesday, N ...
Pharmabiz

AmacaThera inks global licensing agreement with Pacira BioSciences for up to US$ 230 mn, validating its tunable drug delivery platform

AmacaThera inks global licensing agreement with Pacira BioSciences for up to US$ 230 mn, validating its tunable drug delivery platform: Toronto, Ontario Wednesday, November 5, 202 ...
Pharmabiz

Intas Pharma solidifies top 6 rank with double-digit growth in September 2025

Intas Pharma solidifies top 6 rank with double-digit growth in September 2025: Our Bureau, Chennai Wednesday, November 5, 2025, 17:40 Hrs [IST] Ahmedabad-based Intas Pharmaceutica ...
Pharmabiz

Mumbai EOW initiates probe against Medikabazaar current board members and partners for corporate fraud

Mumbai EOW initiates probe against Medikabazaar current board members and partners for corporate fraud: Our Bureau, Mumbai Wednesday, November 5, 2025, 16:15 Hrs [IST] The Economi ...
Pharmabiz

Merck inks pact with Dr Falk Pharma to discontinue certain development and commercialization rights to MK-8690, an investigational anti-CD30 ligand mAb

Merck inks pact with Dr Falk Pharma to discontinue certain development and commercialization rights to MK-8690, an investigational anti-CD30 ligand mAb: Rahway, New Jersey Wednesd ...
Pharmabiz

Valneva reports positive results for phase 1 trial of second generation Zika vaccine candidate, VLA1601

Valneva reports positive results for phase 1 trial of second generation Zika vaccine candidate, VLA1601: Saint-Herblain, France Wednesday, November 5, 2025, 16:00 Hrs [IST] Valnev ...
Pharmabiz

Cipla acquires Inzpera Healthsciences in a deal heralding pharma's new era of empathetic innovation

Cipla acquires Inzpera Healthsciences in a deal heralding pharma's new era of empathetic innovation: Our Bureau, Chennai Wednesday, November 5, 2025, 13:50 Hrs [IST] Pharmaceutica ...
Pharmabiz

Mobisoft Infotech optimizes medical transportation for chronic care patients with an advanced NEMT solution

Mobisoft Infotech optimizes medical transportation for chronic care patients with an advanced NEMT solution: Our Bureau, Bengaluru Wednesday, November 5, 2025, 13:40 Hrs [IST] Mob ...
Pharmabiz

Novavax completes US marketing authorization transfer to Sanofi for Nuvaxovid

US marketing authorization for its Covid-19 vaccine, Nuvaxovid to Sanofi, enabling Sanofi to take full responsibility for commercial and regulatory activities in the US and fulfilling part of its ...
Pharmabiz

Metropolis Healthcare revenues jump by 23% in Q2, interim dividend of 200%

Metropolis Healthcare revenues jump by 23% in Q2, interim dividend of 200%: Our Bureau, Mumbai Wednesday, November 5, 2025, 13:20 Hrs [IST] Metropolis Healthcare, India’s second ...
Pharmabiz

Ajanta Pharma net profit up by 20%, interim dividend of Rs. 28 per share

Ajanta Pharma net profit up by 20%, interim dividend of Rs. 28 per share: Our Bureau, Mumbai Wednesday, November 5, 2025, 13:10 Hrs [IST] Ajanta Pharma, a Rs. 4,600 crore plus pha ...